1. Cp/Heph mutant mice have iron‐induced neurodegeneration diminished by deferiprone. (29th September 2015) Authors: Zhao, Liangliang; Hadziahmetovic, Majda; Wang, Chenguang; Xu, Xueying; Song, Ying; Jinnah, H.A.; Wodzinska, Jolanta; Iacovelli, Jared; Wolkow, Natalie; Krajacic, Predrag; Weissberger, Alyssa Cwanger; Connelly, John; Spino, Michael; Lee, Michael K.; Connor, James; Giasson, Benoit; Leah Harris, Z.;... Journal: Journal of neurochemistry Issue: Volume 135:Number 5(2015:Dec.) Page Start: 958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deferiprone in Friedreich ataxia: A 6‐Month randomized controlled trial. Issue 4 (30th August 2014) Authors: Pandolfo, Massimo; Arpa, Javier; Delatycki, Martin B.; Le Quan Sang, Kim Hanh; Mariotti, Caterina; Munnich, Arnold; Sanz‐Gallego, Irene; Tai, Geneieve; Tarnopolsky, Mark A.; Taroni, Franco; Spino, Michael; Tricta, Fernando Journal: Annals of neurology Issue: Volume 76:Issue 4(2014:Oct.) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Deferiprone‐induced agranulocytosis: 20 years of clinical observations. Issue 10 (4th August 2016) Authors: Tricta, Fernando; Uetrecht, Jack; Galanello, Renzo; Connelly, John; Rozova, Anna; Spino, Michael; Palmblad, Jan Journal: American journal of hematology Issue: Volume 91:Issue 10(2016:Oct.) Page Start: 1026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of renal impairment on the pharmacokinetics of orally administered deferiprone. (18th July 2016) Authors: Fradette, Caroline; Pichette, Vincent; Sicard, Éric; Stilman, Anne; Jayashankar, Shalini; Tsang, Yu Chung; Spino, Michael; Tricta, Fernando Journal: British journal of clinical pharmacology Issue: Volume 82:Number 4(2016:Oct.) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Issue 6 (June 2020) Authors: Maggio, Aurelio; Kattamis, Antonis; Felisi, Mariagrazia; Reggiardo, Giorgio; El-Beshlawy, Amal; Bejaoui, Mohamed; Sherief, Laila; Christou, Soteroula; Cosmi, Carlo; Della Pasqua, Oscar; Del Vecchio, Giovanni Carlo; Filosa, Aldo; Cuccia, Liana; Hassab, Hoda; Kreka, Manika; Origa, Raffaella; Putti,... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years. (6th November 2016) Authors: Bellanti, Francesco; Del Vecchio, Giovanni C.; Putti, Maria C.; Maggio, Aurelio; Filosa, Aldo; Cosmi, Carlo; Mangiarini, Laura; Spino, Michael; Connelly, John; Ceci, Adriana; Della Pasqua, Oscar Journal: British journal of clinical pharmacology Issue: Volume 83:Number 3(2017:Mar.) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Issue 7 (July 2019) Authors: Klopstock, Thomas; Tricta, Fernando; Neumayr, Lynne; Karin, Ivan; Zorzi, Giovanna; Fradette, Caroline; Kmieć, Tomasz; Büchner, Boriana; Steele, Hannah E; Horvath, Rita; Chinnery, Patrick F; Basu, Anna; Küpper, Clemens; Neuhofer, Christiane; Kálmán, Bernadette; Dušek, Petr; Yapici, Zuhal; Wilson, ... Journal: Lancet neurology Issue: Volume 18:Issue 7(2019) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗